CardieX Limited

CDX

AU0000015729

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 01:22:24 2024-05-30 EDT			5-day change	1st Jan Change
0.058 ^AUD	-3.33%		-20.55%	-57.04%

04-02	Australian Shares Inch Down As Market Assesses RBA Policy Meeting Minutes	MT
04-02	Cardiex Marks Two Milestones Toward Wearable Biomarker Technology Commercialization; Shares Up 5%	MT

CardieX Limited Announces Change of Joint Company Secretary

June 17, 2021 at 04:47 am

CardieX Limited announced the appointment of Mr. Nicholas Marshall as Joint Company Secretary who replaces Mr. Philip Leighfield effective 17 June 2021.

Latest news about CardieX Limited

Australian Shares Inch Down As Market Assesses RBA Policy Meeting Minutes	04-02	MT
Cardiex Marks Two Milestones Toward Wearable Biomarker Technology Commercialization; Shares Up 5%	04-01	MT
CARDIEX Secures Higher Credit Facility from C2 Ventures	03-15	MT
CardieX Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-29	CI
CardieX Limited Appoints Charlie Taylor as an Independent Non-Executive Director, Effective 1 March 2024	02-22	CI
CardieX Advances Trade Reinstatement Process with Australian Bourse	01-01	MT
Cardiex Receives Full Settlement of Clinichain Clinical Trial Payments	12-07	MT
Cardiex Limited Announces Mitchell Asset Management Extends Loan Expiration of R&D Facility	11-19	CI
CardieX Limited Announces Resignation of Lesa Musatto as Independent Non-Executive Director	23-10-18	CI
CardieX Limited Announces Sales Results for the First Quarter September 2023	23-10-03	CI
CardieX Limited Announces Resignation of Jarrod White as Interim Chief Financial Officer	23-09-27	CI
CardieX Limited Announces Resignation of Jarrod White as Executive Director	23-09-27	CI
CardieX Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI
CardieX Limited Announces Executive Changes	23-06-29	CI
CardieX Limited Announces Resignation of Reid Yeoman as CFO	23-06-29	CI
CardieX Limited Provides Revenue Guidance for the Fiscal Year 2023	23-06-29	CI
CardieX Limited announced that it expects to receive AUD 4.1 million in funding	23-06-29	CI
CardieX Limited Receives FDA 510(K) Clearance for its Vascular Biometric Monitor - The CONNEQT Pulse	23-04-26	CI
CardieX Secures US FDA Clearance for Blood Pressure Monitoring Device	23-04-26	MT
CardieX Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-28	CI
CardieX to Raise AU$4.5 Million Via Share Placement	23-02-09	MT
CardieX Subsidiary Secures Loan Facility	23-01-06	MT
CardieX Limited Appoints Reid Yeoman as the Group's New Us Based Chief Financial Officer	23-01-06	CI
CardieX Unit Signs Clinical Trial Services Deal for Blood Pressure Device	22-12-09	MT
CardieX Announces Significant New Clinical Trial Agreement	22-12-08	CI

CardieX Limited is an Australia-based digital health technology company. The Company develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. It specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Companyâs SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-28 - Q4 2024 Earnings Release (Projected)

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
CARDIEX LIMITED	-57.04%	11.33M
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.48%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.61B

Other Advanced Medical Equipment & Technology

CardieX Limited

Equities

CDX

AU0000015729

Advanced Medical Equipment & Technology

CardieX Limited Announces Change of Joint Company Secretary

Latest news about CardieX Limited

Chart CardieX Limited

Company Profile

Income Statement Evolution

EPS Revisions

Annual profits - Rate of surprise

Sector Other Advanced Medical Equipment & Technology